Cristina Scavone
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions 15
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 12
-
- Diabetes Treatment and Management 7
- Neurology top 5%
-
- Pharmaceutical studies and practices 10
-
- Multiple Sclerosis Research Studies 8
-
- Drug-Induced Adverse Reactions 7
-
- Biosimilars and Bioanalytical Methods 7
-
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Annalisa CapuanoConcetta RafanielloFrancesco RossiLiberata SportielloAnnamaria MascoloLiberato BerrinoGabriella di MauroMaurizio Sessa
- Journals
- SHILAP Revista de lepidopterología (1 paper)Scientific Reports (1 paper)British Journal of Pharmacology (3 papers)
- Partner nations
- ItalyUruguayUnited Kingdom
In The Last Decade
Cristina Scavone
101 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 131
- Toxicology 199
- Infectious Diseases 468
- Endocrinology, Diabetes and Metabolism 240
- Neurology 216
- Cardiology and Cardiovascular Medicine 308
Countries citing papers authored by Cristina Scavone
This map shows the geographic impact of Cristina Scavone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Scavone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Scavone more than expected).
Fields of papers citing papers by Cristina Scavone
This network shows the impact of papers produced by Cristina Scavone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Scavone. The network helps show where Cristina Scavone may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cristina Scavone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 24 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 33 | |
| 13 | 2021 | 33 | |
| 14 | 2020 | 32 | |
| 15 | 2020 | 7 | |
| 16 | 2020 | 7 | |
| 17 | 2019 | 7 | |
| 18 | Incretin-based therapies and cancer risk: a review of recent literature safety data | 2016 | 2 |
| 19 | 2016 | 32 | |
| 20 | Meningitis y encefalitis víricas en Uruguay: Relevamiento mediante técnicas de reacción en cadena de polimerasa aplicadas al líquido cefalorraquídeo de los grupos herpes, enterovirus y arbovirus como principales agentes etiológicos. A propósito de 59 casos | 2009 | 0 |
About Cristina Scavone
Cristina Scavone is a scholar working on Toxicology, Infectious Diseases and Immunology, having authored 107 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (15 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Pharmaceutical studies and practices (10 papers), Multiple Sclerosis Research Studies (8 papers), Diabetes Treatment and Management (7 papers), Drug-Induced Adverse Reactions (7 papers), Biosimilars and Bioanalytical Methods (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Toxicology (199 citations), Infectious Diseases (468 citations) and Endocrinology, Diabetes and Metabolism (240 citations). Cristina Scavone has collaborated with scholars based in Italy, Uruguay and United Kingdom. Frequent co-authors include Annalisa Capuano, Concetta Rafaniello, Francesco Rossi, Liberata Sportiello, Annamaria Mascolo, Liberato Berrino, Gabriella di Mauro, Maurizio Sessa, Giorgio Racagni and Antonella De Angelis. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.